{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:55:29Z","timestamp":1763535329733},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T00:00:00Z","timestamp":1423008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00393-014-1524-7","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T21:02:50Z","timestamp":1422910970000},"page":"363-369","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dermatomyositisspezifische Antik\u00f6rper"],"prefix":"10.1007","volume":"74","author":[{"given":"L.","family":"Bodoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nagy-Vincze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Griger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dank\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,4]]},"reference":[{"key":"1524_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"1524_CR2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/berh.2002.0261","volume":"16","author":"Dorph","year":"2002","unstructured":"Dorph C, Lundberg IE (2002) Idiopathic inflammatory myopathies \u2013 myositis. Best Pract Res Clin Rheumatol 16:817\u2013832","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1524_CR3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00393-005-0664-1","volume":"64","author":"Kim","year":"2005","unstructured":"Kim S, Genth E, Krieg T, Hunzelmann N (2005) PM-Scl-Antik\u00f6rper positive systemische Sklerodermie assoziiert mit Einschl\u00fcssk\u00f6rper-Myositis. Z Rheumatol 64:499\u2013502","journal-title":"Z Rheumatol"},{"key":"1524_CR4","first-page":"39","volume":"54","author":"Genth","year":"1995","unstructured":"Genth E, Mierau R (1995) Diagnostische Bedeutung Sklerodermie- und Myositis-assoziierter Autoantik\u00f6rper. Z Rheumatol 54:39\u201349","journal-title":"Z Rheumatol"},{"key":"1524_CR5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"Brouwer","year":"2001","unstructured":"Brouwer R, Hengstman GJ, Vree Egberts W et al (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60:116\u2013123","journal-title":"Ann Rheum Dis"},{"key":"1524_CR6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2169\/internalmedicine.51.6566","volume":"51","author":"Sugie","year":"2012","unstructured":"Sugie K, Tonomura Y, Ueno S (2012) Characterization of dermatomyositis with coexistence of anti-Jo-1 and anti-SRP antibodies. Intern Med 51:799\u2013802","journal-title":"Intern Med"},{"key":"1524_CR7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.bor.0000434664.37880.ac","volume":"25","author":"Tansley","year":"2013","unstructured":"Tansley SL, Betteridge ZE, McHugh NJ (2013) The diagnostic utility of autoantibodies in adult and juvenile myositis. Curr Opin Rheumatol 25:772\u2013777","journal-title":"Curr Opin Rheumatol"},{"key":"1524_CR8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar3275","volume":"13","author":"Betteridge","year":"2011","unstructured":"Betteridge ZE, Gunawardena H, McHugh NJ (2011) Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther 13:209","journal-title":"Arthritis Res Ther"},{"key":"1524_CR9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","volume":"12","author":"Targoff","year":"2000","unstructured":"Targoff IN (2000) Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol 12:475\u2013481","journal-title":"Curr Opin Rheumatol"},{"key":"1524_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00105-009-1897-8","volume":"61","author":"Volc-Platzer","year":"2010","unstructured":"Volc-Platzer B (2010) Update: Dermatomyositis. Hautarzt 61:69\u201378","journal-title":"Hautarzt"},{"key":"1524_CR11","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3899\/jrheum.111604","volume":"39","author":"Stanciu","year":"2012","unstructured":"Stanciu R, Guiquet M, Musset L et al (2012) Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use. J Rheumatol 39:1835\u20131839","journal-title":"J Rheumatol"},{"key":"1524_CR12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","volume":"11","author":"Marie","year":"2012","unstructured":"Marie I, Josse S, Decaux O et al (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11:739\u2013745","journal-title":"Autoimmun Rev"},{"key":"1524_CR13","doi-asserted-by":"crossref","unstructured":"Labirua-Iturburu A, Selva-O\u2019Callaghan A, Vincze M et al (2012) Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore) 91:206\u2013211","DOI":"10.1097\/MD.0b013e318260977c"},{"key":"1524_CR14","doi-asserted-by":"crossref","unstructured":"Rigolet A, Musset L, Dubourg O et al (2012) Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine (Baltimore) 91:95\u2013102","DOI":"10.1097\/MD.0b013e31824d9cec"},{"key":"1524_CR15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BOR.0b013e32834b324b","volume":"23","author":"Liang","year":"2011","unstructured":"Liang C, Needham M (2011) Necrotizing autoimmune myopathy. Curr Opin Rheumatol 23:612\u2013619","journal-title":"Curr Opin Rheumatol"},{"key":"1524_CR16","doi-asserted-by":"crossref","unstructured":"Allenbach Y, Drouot L, Rigolet A et al (2014) Anti-HMGCR autoantibodies in european patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) 93:150\u2013157","DOI":"10.1097\/MD.0000000000000028"},{"key":"1524_CR17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","volume":"28","author":"Targoff","year":"1985","unstructured":"Targoff IN, Reichlin M (1985) The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28:796\u2013803","journal-title":"Arthritis Rheum"},{"key":"1524_CR18","doi-asserted-by":"crossref","unstructured":"Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360\u2013374","DOI":"10.1097\/00005792-199111000-00002"},{"key":"1524_CR19","doi-asserted-by":"crossref","unstructured":"Cruellas MG, Viana Vdos S, Levy-Neto M et al (2013) Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (Sao Paulo) 68:909\u2013914","DOI":"10.6061\/clinics\/2013(07)04"},{"key":"1524_CR20","doi-asserted-by":"crossref","unstructured":"Rider LG, Shah M, Mamyrova G et al (2013) The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92:223\u2013243","DOI":"10.1097\/MD.0b013e31829d08f9"},{"key":"1524_CR21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/ar4207","volume":"15","author":"Petri","year":"2013","unstructured":"Petri MH, Satoh M, Martin-Marquez BT et al (2013) Implications in the difference of anti-Mi-2 and -p155\/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara. Arthritis Res Ther 15:48","journal-title":"Arthritis Res Ther"},{"key":"1524_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Hamaguchi","year":"2011","unstructured":"Hamaguchi Y, Kuwana M, Hoshino K et al (2011) Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 147:391\u2013398","journal-title":"Arch Dermatol"},{"key":"1524_CR23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","volume":"55","author":"Selva-O","year":"2006","unstructured":"Selva-O\u2019Callaghan A, Labrador-Horrillo M, Solans-Laque R et al (2006) Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55:791\u2013798","journal-title":"Arthritis Rheum"},{"key":"1524_CR24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/ard.2005.040717","volume":"65","author":"Hengstman","year":"2006","unstructured":"Hengstman GJ, Vree Egberts WT, Seelig HP et al (2006) Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann Rheum Dis 65:242\u2013245","journal-title":"Ann Rheum Dis"},{"key":"1524_CR25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2011-200871","volume":"71","author":"Labrador-Horrillo","year":"2012","unstructured":"Labrador-Horrillo M, Mart\u00ednez MA, Selva-O\u2019Callaghan A et al (2012) Anti-TIF1\u03b3 antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays. Ann Rheum Dis 71:993\u2013996","journal-title":"Ann Rheum Dis"},{"key":"1524_CR26","first-page":"449","volume":"65","author":"Fujimoto","year":"2013","unstructured":"Fujimoto M (2013) Myositis-specific autoantibodies. Brain Nerve 65:449\u2013460 (Article in Japanese)","journal-title":"Brain Nerve"},{"key":"1524_CR27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","volume":"150","author":"Valenzuela","year":"2014","unstructured":"Valenzuela A, Chung L, Casciola-Rosen L et al (2014) Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatol 150:724\u2013729","journal-title":"JAMA Dermatol"},{"key":"1524_CR28","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","volume":"68","author":"Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, Chinoy H et al (2009) Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis 68:1621\u20131625","journal-title":"Ann Rheum Dis"},{"key":"1524_CR29","unstructured":"Ceribelli A, Fredi M, Taraborelli M et al (2014) Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis\/dermatomyositis. Clin Exp Rheumatol (Epub ahead of print)"},{"key":"1524_CR30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12016-013-8387-6","volume":"47","author":"Tansley","year":"2013","unstructured":"Tansley S, Gunawardena H (2013) The evolving spectrum of polymyositis and dermatomyositis-moving towards clinicoserological syndromes: a critical review. Clin Rev Allergy Immunol 47(3):264\u2013273","journal-title":"Clin Rev Allergy Immunol"},{"key":"1524_CR31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Hamaguchi","year":"2011","unstructured":"Hamaguchi Y, Kuwana M, Hoshino K et al (2011) Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 147:391\u2013398","journal-title":"Arch Dermatol"},{"key":"1524_CR32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","volume":"65","author":"Fiorentino","year":"2011","unstructured":"Fiorentino D, Chung L, Zwerner J et al (2011) The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 65:25\u201334","journal-title":"J Am Acad Dermatol"},{"key":"1524_CR33","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar4600","volume":"16","author":"Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Gunawardena H et al (2014) Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther 16:R138","journal-title":"Arthritis Res Ther"},{"key":"1524_CR34","first-page":"234","volume":"38","author":"Peixoto","year":"2013","unstructured":"Peixoto D, Costa J, Ferretti M et al (2013) New autoantibodies and their clinical associations in juvenile myositis \u2013 a systematic review. Acta Reumatol Port 38:234\u2013241","journal-title":"Acta Reumatol Port"},{"key":"1524_CR35","doi-asserted-by":"crossref","unstructured":"Bodoki L, Nagy-Vincze M, Griger Z et al (2014) Four dermatomyositis-specific autoantibodies-anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev (Epub ahead of print)","DOI":"10.1016\/j.autrev.2014.08.011"},{"key":"1524_CR36","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1556\/OH.2014.29984","volume":"155","author":"Szankai","year":"2014","unstructured":"Szankai Z, Nagy-Vincze M, Bodoki L et al (2014) Risk factors for cancer in patients with myositis. Clinical, immunological characteristics and the role of the anti-p155\/140 antibody. Orv Hetil 155:1437\u20131444 (Article in Hungarian)","journal-title":"Orv Hetil"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1524-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-014-1524-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1524-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T10:35:01Z","timestamp":1566297301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-014-1524-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1007\/s00393-014-1524-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,4]]}}}